40 related articles for article (PubMed ID: 38686946)
1. The prognostic value of MGMT promoter methylation in glioblastoma: A meta-analysis of clinical trials.
Binabaj MM; Bahrami A; ShahidSales S; Joodi M; Joudi Mashhad M; Hassanian SM; Anvari K; Avan A
J Cell Physiol; 2018 Jan; 233(1):378-386. PubMed ID: 28266716
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of MGMT promoter status by pyrosequencing assay for glioblastoma patients' survival: a meta-analysis.
Zhao H; Wang S; Song C; Zha Y; Li L
World J Surg Oncol; 2016 Oct; 14(1):261. PubMed ID: 27733166
[TBL] [Abstract][Full Text] [Related]
3. Clinical role of NDRG2-based methylation status on survival pattern of glioblastoma.
Swellam M; Khalifa MK; Nageeb AM; Ezz El-Arab L; El-Mahdy M; El-Bahy K; Sayed Mahmoud M
Int J Immunopathol Pharmacol; 2024; 38():3946320241250294. PubMed ID: 38686946
[TBL] [Abstract][Full Text] [Related]
4. Promoter methylation of AREG, HOXA11, hMLH1, NDRG2, NPTX2 and Tes genes in glioblastoma.
Skiriutė D; Vaitkienė P; Ašmonienė V; Steponaitis G; Deltuva VP; Tamašauskas A
J Neurooncol; 2013 Jul; 113(3):441-9. PubMed ID: 23624749
[TBL] [Abstract][Full Text] [Related]
5. MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay?
Yamashita S; Yokogami K; Matsumoto F; Saito K; Mizuguchi A; Ohta H; Takeshima H
J Neurosurg; 2018 May; 130(3):780-788. PubMed ID: 29726772
[TBL] [Abstract][Full Text] [Related]
6. NDRG2 and NDRG4 Expression Is Altered in Glioblastoma and Influences Survival in Patients with MGMT-methylated Tumors.
Kolodziej MA; Weischer C; Reinges MH; Uhl E; Weigand MA; Schwarm FP; Schänzer A; Acker T; Quint K; Uhle F; Stein M
Anticancer Res; 2016 Mar; 36(3):887-97. PubMed ID: 26976975
[TBL] [Abstract][Full Text] [Related]
7. Arterial spin labeling perfusion-weighted imaging aids in prediction of molecular biomarkers and survival in glioblastomas.
Yoo RE; Yun TJ; Hwang I; Hong EK; Kang KM; Choi SH; Park CK; Won JK; Kim JH; Sohn CH
Eur Radiol; 2020 Feb; 30(2):1202-1211. PubMed ID: 31468161
[TBL] [Abstract][Full Text] [Related]
8. Defining optimal cutoff value of MGMT promoter methylation by ROC analysis for clinical setting in glioblastoma patients.
Yuan G; Niu L; Zhang Y; Wang X; Ma K; Yin H; Dai J; Zhou W; Pan Y
J Neurooncol; 2017 May; 133(1):193-201. PubMed ID: 28516344
[TBL] [Abstract][Full Text] [Related]
9. Integration of gene expression and DNA methylation data across different experiments.
Itai Y; Rappoport N; Shamir R
Nucleic Acids Res; 2023 Aug; 51(15):7762-7776. PubMed ID: 37395437
[TBL] [Abstract][Full Text] [Related]
10. Aggressiveness of Grade 4 Gliomas of Adults.
Deacu M; Docu Axelerad A; Popescu S; Topliceanu TS; Aschie M; Bosoteanu M; Cozaru GC; Cretu AM; Voda RI; Orasanu CI
Clin Pract; 2022 Sep; 12(5):701-713. PubMed ID: 36136867
[TBL] [Abstract][Full Text] [Related]
11. The Function of N-Myc Downstream-Regulated Gene 2 (NDRG2) as a Negative Regulator in Tumor Cell Metastasis.
Lee KW; Lim S; Kim KD
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012631
[TBL] [Abstract][Full Text] [Related]
12. Glioblastoma as an age-related neurological disorder in adults.
Kim M; Ladomersky E; Mozny A; Kocherginsky M; O'Shea K; Reinstein ZZ; Zhai L; Bell A; Lauing KL; Bollu L; Rabin E; Dixit K; Kumthekar P; Platanias LC; Hou L; Zheng Y; Wu J; Zhang B; Hrachova M; Merrill SA; Mrugala MM; Prabhu VC; Horbinski C; James CD; Yamini B; Ostrom QT; Johnson MO; Reardon DA; Lukas RV; Wainwright DA
Neurooncol Adv; 2021; 3(1):vdab125. PubMed ID: 34647022
[TBL] [Abstract][Full Text] [Related]
13. Sex-Specific Differences in Glioblastoma.
Carrano A; Juarez JJ; Incontri D; Ibarra A; Guerrero Cazares H
Cells; 2021 Jul; 10(7):. PubMed ID: 34359952
[TBL] [Abstract][Full Text] [Related]
14. DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival.
Weng JY; Salazar N
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498463
[TBL] [Abstract][Full Text] [Related]
15. Management of glioblastoma: State of the art and future directions.
Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
